-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Mucopolysaccharidosis III (MPS III)...
-
Product Insights
Lianyungang Yuntai Phase III Solar PV Project, China
Lianyungang Yuntai Phase III Solar PV Project is proposed to be built in Jiangsu, China. The project is at the permitting stage. Empower your strategies with our Lianyungang Yuntai Phase III Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
Bitcoin Mining Center Solar PV Park III, US
Bitcoin Mining Center Solar PV Park III is proposed to be built in Texas, United States. The project is at the permitting stage. Empower your strategies with our Bitcoin Mining Center Solar PV Park III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
Antithrombin III – Drugs In Development, 2023
Global Markets Direct’s Antithrombin III provides in depth analysis on Antithrombin III targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Antithrombin III targeted therapeutics development and features...
-
Product Insights
Exodeoxyribonuclease III – Drugs In Development, 2023
Global Markets Direct’s Exodeoxyribonuclease III provides in depth analysis on Exodeoxyribonuclease III targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Exodeoxyribonuclease III targeted therapeutics development and features...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DNL-126 in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DNL-126 in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DNL-126 in Mucopolysaccharidosis III (MPS III) (Sanfilippo...
-
Product Insights
Apolipoprotein C III – Drugs In Development, 2023
Global Markets Direct’s Apolipoprotein C III provides in depth analysis on Apolipoprotein C III targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Apolipoprotein C III targeted therapeutics...
-
Product Insights
Panattoni – City Logistics Poznan III – Greater Poland Voivodeship
The Panattoni – City Logistics Poznan III – Greater Poland Voivodeship project involves the construction of a 44,000m2 logistics center in Poznan, Greater Poland Voivodeship, Poland. Equip yourself with the essential tools needed to make informed and profitable decisions with our Panattoni – City Logistics Poznan III – Greater Poland Voivodeship report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends...